Aberrant cytokine and VCAM-1 expression in patients with viral and non-viral related liver cirrhosis

Cytokine. 2023 Nov:171:156385. doi: 10.1016/j.cyto.2023.156385. Epub 2023 Oct 1.

Abstract

The study aim was to compare the alterations in the expression levels of proinflammatory and chemotactic cytokines as tumor necrosis factor-alpha (TNF-α), interleukin (IL)-17A and IL-8, the down regulatory cytokine IL-10, in addition to the vascular cell adhesion molecule-1 (VCAM-1) gene in different groups of patients with cirrhosis due to various etiologies. This case-control study included 84 patients suffering from cirrhosis of viral and non-viral etiologies and 20 sex and age-matched healthy controls. All patients were subjected to detailed history taking, clinical examination, and liver function assessment. The expression levels of TNF-α, IL-17A, IL-8, IL-10, and VCAM-1 were assessed in peripheral blood mononuclear cells by real-time PCR. Patients with cirrhosis showed marked changes in the tested gene expression levels relative to the control group. Higher expression levels of all genes except IL-10 were seen in patients of the viral than in the non-viral groups. Most of the significant correlations of liver function parameters were observed with TNF-α in both the viral and non-viral groups, followed by IL-17A. Increased TNF-α and IL-17A presented potential risk factors for disease progression to cirrhosis of Child class C.

Keywords: Cirrhosis; IL-10; IL-17A; IL-8; TNF- α.

MeSH terms

  • Case-Control Studies
  • Child
  • Cytokines*
  • Humans
  • Interleukin-10
  • Interleukin-17 / genetics
  • Interleukin-8
  • Leukocytes, Mononuclear / metabolism
  • Liver Cirrhosis / genetics
  • Tumor Necrosis Factor-alpha / metabolism
  • Vascular Cell Adhesion Molecule-1* / genetics

Substances

  • Cytokines
  • Vascular Cell Adhesion Molecule-1
  • Interleukin-10
  • Tumor Necrosis Factor-alpha
  • Interleukin-17
  • Interleukin-8